Policy changes Backwork has recorded, newest first. The most recent change on record is from October 24, 2026. Changes appear here after Backwork reviews and applies a refresh, so this page can trail the payers’ own sites.
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
86,510 on record
| Recorded | Payer | Policy | Change |
|---|---|---|---|
| May 25, 2026 | CMS / Medicare | Molecular Pathology Procedures | Codes changed |
| May 25, 2026 | CMS / Medicare | Non-Invasive Vascular Studies | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Testing for Identification and Management of Hereditary Transthyretin Amyloidosis | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Genetic Testing for Heritable Thoracic Aortic Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Non-Next Generation Sequencing Tests for the Diagnosis of BCR-ABL Negative Myeloproliferative Neoplasms | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Gene Expression Profile Tests for Decision-Making in Castration Resistant and Metastatic Prostate Cancers | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Testing for Risk Stratification of Thyroid Nodules | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Biomarkers for Risk Stratification of Indeterminate Pulmonary Nodules Following Bronchoscopy | Codes changed |
| May 25, 2026 | CMS / Medicare | Intraosseous Basivertebral Nerve Ablation | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis | Codes changed |
| May 25, 2026 | CMS / Medicare | Sacroiliac Joint Injections and Procedures | Codes changed |
| May 25, 2026 | CMS / Medicare | Allogeneic Hematopoietic Cell Transplantation for Primary Refractory or Relapsed Hodgkin's and Non-Hodgkin's Lymphoma with B-cell or T-cell Origin | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Assays for the Diagnosis of Cutaneous Melanoma | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Testing for Detection of Upper Gastrointestinal Metaplasia, Dysplasia, and Neoplasia | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Plasma-Based Genomic Profiling in Solid Tumors | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Biomarkers to Risk-Stratify Patients at Increased Risk for Prostate Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Syndromic Panels for Infectious Disease Pathogen Identification Testing | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Lab-Developed Tests for Inherited Cancer Syndromes in Patients with Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Minimal Residual Disease Testing for Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | Facet Joint Interventions for Pain Management | Codes changed |
| May 25, 2026 | CMS / Medicare | Transurethral Waterjet Ablation of the Prostate | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Prognostic and Predictive Molecular Classifiers for Bladder Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Phenotypic Biomarker Detection from Circulating Tumor Cells | Codes changed |
| May 25, 2026 | CMS / Medicare | Non-Invasive Fractional Flow Reserve (FFR) for Ischemic Heart Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Prostate Cancer Genomic Classifier Assay for Men with Localized Disease | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Pharmacogenomics Testing | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Blood Product Molecular Antigen Typing | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Predictive Classifiers for Early Stage Non-Small Cell Lung Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Pigmented Lesion Assay | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Next-Generation Sequencing Lab-Developed Tests for Myeloid Malignancies and Suspected Myeloid Malignancies | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Next-Generation Sequencing for Solid Tumors | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Inivata, InvisionFirst, Liquid Biopsy for Patients with Lung Cancer | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Envisia, Veracyte, Idiopathic Pulmonary Fibrosis Diagnostic Test | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Breast Cancer Index (BCI) Gene Expression Test | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Melanoma Risk Stratification Molecular Testing | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: EndoPredict Breast Cancer Gene Expression Test | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: DecisionDx-UM (Uveal Melanoma) | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Oncotype DX Breast Cancer for DCIS (Genomic Health) | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: HLA-DQB1*06:02 Testing for Narcolepsy | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Breast Cancer Assay: Prosigna | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Biomarkers in Cardiovascular Risk Assessment | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: NRAS Genetic Testing | Codes changed |
| May 25, 2026 | CMS / Medicare | MolDX: Molecular Diagnostic Tests (MDT) | Codes changed |